SCHEMBL23937759

SCHEMBL23937759

CNS(=O)(=O)c1cc(O)c2ccn(C)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
GAA P10253 1/20 0.36
KDM4E B2RXH2 1/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
PKM P14618 3/20 0.35
MAPK1 P28482 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA13 Q8N1Q1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20674254 0.83 PIK3CG (0.42) CA12CA1CA2CA9ALDH1A1
SCHEMBL20674256 0.77 TSHR (0.32) TSHR
SCHEMBL20674086 0.75 TSHR (0.40) TSHRSMN1; SMN2LMNAGAAKDM4E
SCHEMBL23937757 0.74 PKM (0.35) TSHRLMNAKDM4EPKML3MBTL1
SCHEMBL23937675 0.71 TUBB4A (0.39) TSHRSMN1; SMN2HTTKDM4ECA2
SCHEMBL23937755 0.71 FTO (0.36) TSHRLMNAPKML3MBTL1FTO
SCHEMBL10153740 0.70 PKM (0.62) SMN1; SMN2LMNAHTTGAAPKM
SCHEMBL9143971 0.68 SERPINE1 (0.70) TSHRSMN1; SMN2LMNAHTTGAA
SCHEMBL10153951 0.67 RORC (0.41) KDM4ECA2FTOALDH1A1HTR6
SCHEMBL20674246 0.67 BRD4 (0.42) SMN1; SMN2KDM4EALDH1A1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed